Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation

Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation

Kanqiu Jiang,* Mingjing Shen,* Weihua Xu Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou Shi, Jiangsu Sheng, People’s Republic of China *These authors contributed equally to this work Purpose: In this study, a novel arginine, glycine, a...

Full description

Bibliographic Details
Main Authors: Jiang K, Shen M, Xu W
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:International Journal of Nanomedicine
Subjects:
RGD
Paclitaxel
Curcumin
liposome
Cell uptake
Cytotoxicity study
In vivo anti-tumor study
Online Access:https://www.dovepress.com/arginine-glycine-aspartic-acid-peptide-modified-paclitaxel-and-curcumi-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/arginine-glycine-aspartic-acid-peptide-modified-paclitaxel-and-curcumi-peer-reviewed-article-IJN

Similar Items